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Abstract 
Rab proteins are ras-like low molecular mass GTP-binding proteins, which are postulated to act as specific regulators of membrane trafficking 
m exocytosis and endocytosis. We have previously shown that synthetic peptides, corresponding to the effector domain of Rab3 proteins, stimulate 
a complete exocytotic response in mast cells. We have used a PCR-clomng strategy to investigate the presence of mRNA encoding Rab3 in mast 
cells. RNA based PCR was then performed on mast cell RNA using degenerate oligonucleotide primers based on two conserved sequences among 
Rab3 proteins. However, no PCR products were obtained, even for proteins known to be expressed in high copy numbers in mast cells @-actin and 
Fc receptor). We have found that the problem resides in the presence of mast cell secretory granule derived heparin, that copurifies with the RNA; 
heparin has been shown to inhibit the activity of reverse transcriptase and Taq polymerase in PCR. After treating the RNA (obtained from about 
500 mast cells) with heparinase, several PCR products of varying size were obtained using primers specific for Rab3 proteins. These products were 
cloned and sequenced. We have found clones containing sequences that had a 100% homology at the deduced amino acid level to a portion of Rab3B 
and Rab3D (amino acids 16 to 83). 
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1. Introduction 
Recently, the diverse superfamily of small GTP-bind- 
ing proteins have been implicated in the regulation of 
many aspects of cellular dynamics. Members of the Rab 
family have been implicated as important regulators of 
vesicle trafficking and membrane fusion [l-3]. More 
than 30 members of the Rab family have been identified. 
It is thought that each Rab protein controls a specific 
vesicular transport event [3]. For instance, Rab3A, one 
isoform of Rab3 has been implicated in neurotransmitter 
secretion because it has been found only in secretory cells 
[4,5], is localized to synaptic vesicles [6,7] and undergoes 
cellular redistribution during exocytosis [7]. It seems that 
there are different Rab3 isotypes controlling exocytosis 
in different cell types. Rab3D has been proposed to reg- 
ulate the exocytotic fusion of vesicles carrying the glu- 
cose transporter GLUT-4 in adipocytes [8]. Rab3B has 
been shown to have an essential role in exocytosis in 
pituitary cells, because inhibition of expression of Rab3B 
with antisense oligonucleotides markedly reduced Ca2’- 
dependent exocytotic fusion [9]. 
We have recently shown that synthetic oligopeptides, 
corresponding to the proposed effector domain of Rab3 
proteins [lo], stimulate a complete exocytotic response in 
mast cells [l 11. These peptides have since been shown to 
produce a similar effect in several other cell types. For 
example in pancreatic acinar cells [12,13], adrenal chro- 
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maffin cells [ 141, insulin secreting cells [15], Helisoma 
cells [16] and in an exocytotis reconstitution system [171. 
The mechanism of action of Rab3 peptides is not known; 
a plausible hypothesis is that the peptides directly acti- 
vate the Rab3 effector proteins. We proposed that a 
sustained activation of a Rab3 protein was a sufficient 
stimulus for exocytosis in mast cells, and that this protein 
must be an integral part of the scaffold of proteins that 
causes exocytotic fusion [ 11,181. An essential component 
of this hypothesis is the presence of Rab3 proteins in 
peritoneal mast cells. Their identification will permit the 
design of electrophysiological experiments to test their 
role in exocytosis. Peritoneal mast cells have been notori- 
ously difficult to use in molecular biological experiments, 
requiring large numbers of animals and with modest 
results [19,20]. In this paper we report a simple method- 
ology that allows RNA based PCR (RT-PCR) cloning 
from a small number of peritoneal mast cells (100 to 
500). Using these methodologies we have detected the 
expression, in mast cells, of two members of the Rab3 
family, Rab3B and Rab3D. 
2. Materials and methods 
2.1. Cell preparalion 
Total peritoneal cells (about 50% macrophages and 2% mast cells) 
were isolated from mouse or rat by peritoneal avage [21]. Mast cells 
were purified using a metrizamide gradient (about 95% pure) [22]. To 
obtain a small number of mast cells, the purified cells were plated on 
glass bottom chambers, and individual mast cells were aspirated into 
a glass micropipette under Norma&l optics. Mast cells were readily 
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distinguished from other cell types by then characteristic morphology. 
The rat basophilic leukemia cell line RBL-1 was obtained from ATCC. 
2.2 RNA preparation 
Total RNA was extracted using an RNA STAT-60 kit (Tel-Test ‘B’ 
Inc. TEXAS) which is based on the method developed by Chomczynski 
and Sacchi [23]. To obtain RNA from a small number of mast cells, a 
glass micropipette containing mast cells was immersed in lysis buffer 
and sonicated (Branson model 450 sonifier, Branson Ultrasonics corpo- 
ration, Danbury CT. Settings: Duty cycle 22%. Output control 25% for 
6-7 pulses until the glass micropipette was broken to small pieces). 
Total RNA was then isolated according to kit instructions. using lo-20 
pug of E. coli transfer RNA (Boehringer Mannheim) as a carrier. 
2.3. Heparinase treatment of RNA 
Total RNA was incubated with heparmase I (Sigma, 5 umts/pg 
RNA) in 5 mM Trls pH 7.5,l mM CaCl>, 50 units of RNasin (Promega) 
for 2 h at 25°C to remove native mast cell heparin. 
2.4 Reverse transcription and PCR 
Approximately 1 pg of RNA was reverse transcribed at 37°C for 
60 min with a mixture of 200 U of Moloney murine leukemia virus reverSe 
transcriptase (Bethesda Research Laboratories, Gaithersburg, MD), 
5 PM random primers and 1 mM of each dNTP. The cDNA product 
was subjected to PCR using primers for Rab3,B-actin, and Fc&RI. The 
Rab3 primers target a region that is specific for Rab3 proteins 
(DQNFDYM) and a region that is highly conserved between Rab 
proteins (WDTAGQE) [2,8,24]. The Rab3 primers are degenerate to 
accommodate for the codon uncertainty and flank a region of 201 bp. 
The primers for Rab3: 5’-GAY-CAR-AAY-TTY-GAY-TAY-ATG-3’ 
and 5’-YTC-YTG-NCC-NGC-NGT-RTC-CCA-3’. R is A or G; Y is 
C or T and N is any. For the PCR the cDNA and 100pM ofeach primer 
in lOO@ of reaction mix (Gene Amp PCR core reagents, Perkm-Elmer) 
containing 1.5 mM M.&l, were used. The temperature cycles were 
15 s at 94”C, 30 s at 45”C;and 20 s at 72°C. b-A&in and Fc receptors 
were used as oositive controls. Primers for B-actin: 5’-ATG-CCT-CTG- 
GTC-GTA-6CA-CGG-GCA-TTG-3’ anh 5’-CTT-GCT-GAT-CCA- 
CAT-CTG-CTG-GAA-GGT-3’ (flanking a region of 650 bp) [25]. 
Primers for FcERI: 5’-TKG-GTC-ATT-GTG-AGT-GCC-ACC-3’ and 
5’-GTG-TCC-ACA-GCA-AAC-AGA-ATC-3’ (flanking a region of 
430 bp) [26]. We routinely included negative controls in the RT-PCR 
protocol (‘no template’ (no cDNA template) and ‘no RT’ (no reverse 
transcriptase) to rule out amplification of DNA from contaminating 
sources. In addition, m some experiments the purified RNA was pre- 
treated with DNase I (5 U/pg RNA for 15 min) to eliminate any trace 
contaminant genomic DNA. However, this treatment did not change 
the results. PCR products were detected by electrophoresis nethldium 
bromide stained agarose gels. 
2.5 Subcloning and sequencing of PCR products 
The PCR products were spliced into the PCR ready pCR II plasmid 
(TA cloning kit, Invitrogen, San Diego, CA), cloned and sequenced 
using a dideoxy termination sequencing kit (United States Biochemical 
Corp. Cleveland, OH). 
2.6. Denaturmg gel electrophoresis for RNA 
The quality of the isolated RNA was checked using formaldehyde, 
denaturing agarose gel electrophoresis (1.5 h, 70 V) [27]. 1-3 pg samples 
of total RNA were applied to the gels. 
3. Results 
Total peritoneal cells (- 50% macrophages. - 2% mast 
cells) were isolated from a mouse or a rat by peritoneal 
lavage. RT-PCR was performed as previously described 
[25]. l-3 ,ug of RNA were reverse transcribed with a 
mixture Moloney Murine Leukemia Virus (MMLV) re- 
verse transcriptase and random hexamer primers. How- 
ever, when the cDNA product was subjected to PCR 
using primers for B-actin, no bands were detected after 
1 2 3 4 5 
Fig. 1. RT-PCR in peritoneal cells. Agarose gel electrophoresis of 
RT-PCR products for /?-actin mRNA from total peritoneal cells and 
rat basophilic leukemia (RBL) cells. First lane, DNA size standards; 
lane 1, PCR products from peritoneal cells RNA (3 pg) obtained after 
60 cycles at 95°C 15 s, 50°C 25 s, 72°C 20 s; lane 2, PCR products from 
RBL RNA (0.5 pup) obtained after 30 PCR cycles; lane 3. PCR products 
from a 1.1 mixture of RBL and peritoneal cells RNA (1 pg of each); 
lane 4, PCR products from peritoneal cell RNA (1 pg) treated with 
heparinase; lane 5, PCR products from RBL cell RNA (0.5 pug) treated 
with heparinase. The PCR products in lanes 3 to 6 were obtained after 
30 cycles at 95°C 15 s, 54°C 25 s, 72°C 20 s. 
electrophoresis in ethidium bromide stained agarose 
gels, even after 60 PCR cycles (Fig. 1, lane 1). This was 
unexpected, since /?-actin is an ubiquitous gene product 
that has been shown to be expressed in high copy num- 
bers in mouse peritoneal macrophages [25]. Amplifica- 
tion of /?-actin fragments was however possible from 
RNA isolated from a ‘mast cell like’ cell line, rat baso- 
philic leukemia cells (RBL) (Fig. 1, lane 2). Surprisingly, 
we were unable to amplify /?-actin fragments upon mix- 
ing RNA from freshly isolated peritoneal cells and RBL 
cells in equal amounts (Fig. 1, lane 3). One possible 
explanation for these results would be that the RNA is 
degraded due to contamination of the mast cell RNA 
with RNases. We therefore analyzed the RNA integrity 
by denaturing agarose electrophoresis. This analysis 
showed that the 28 S and 18 S ribosomal bands of peri- 
toneal cells RNA were intact, indicating very little or no 
RNA degradation during the isolation (not shown). So, 
it is unlikely that the lack of amplification shown in lanes 
1 and 3 of Fig. 1 was due to RNase contamination. These 
results suggest that the peritoneal mast cell RNA contain 
inhibitors of PCR. 
Several inhibitors of PCR have been described [28]. 
Heparin has been shown to inhibit the activity of MMLV 
reverse transcriptase and Taq polymerase [29]. As 
peritoneal mast cell have large quantities of the heparin 
proteoglycan in their secretory granules, we therefore 
investigated if treating peritoneal mast cell RNA with 
heparinase would allow RT-PCR. We have found that 
after incubation of the RNA with heparinase I (5 units 
per ,ug RNA) for 2 h at 25°C amplification of cDNA 
fragments by PCR was easily accomplished (Fig. 1, lane 4). 
Using this method we were able to obtain PCR prod- 
ucts with degenerate primers for Rab3 proteins, using the 
RNA isolated from a large number of peritoneal mast 
cells (about lo6 cells) (Fig. 2A). However, although the 
purity of the mast cell samples was very high (about 95%) 
it was difficult to be certain about the origin of the PCR 
products. To demonstrate the presence of Rab3 mRNA 
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A. B. expected, the products of the PCR reaction obtained 
with the Rab3 degenerate primers migrated in a 3% aga- 
rose gel as a band of approximately 200 bases. These 
PCR products were ligated into a TA cloning pCRI1 
vector (Invitrogen). About 100 positive clones were ob- 
tained and 5 were sequenced. The nucleotide sequence 
and the deduced amino acid sequence are shown in Fig. 
3B. Three of these clones were 100% identical to Rab3B 
and the other two were identical to Rab3D (amino acids 
16 to 83). To demonstrate the specificity of this method, 
we subcloned and sequenced Rab3 PCR products ob- 
tained from total mouse brain RNA. Two out of a total 
of 25 positive clones were sequenced and found that they 
were 100% identical to the mouse Rab3a nucleotide se- 
quence [5]. 
Fig. 2. (A) Detection of Rab3 (lane 1) and/I-actin (lane 2) PCR products 
from RNA isolated from lo6 purified rat peritoneal mast cells. The PCR 
consisted of 30 cycles of 94°C 15s, 45’C 30 s, 72°C 20 s, with 1 ,uM 
of degenerate primers for Rab3 proteins. (B) Detection of/I-actin (lanes 
1,2) and FcERI (lanes 3,4) cDNA from about 500 individually picked 
peritoneal mast cells from a rat (lanes 1,3) and a mouse (lanes 2,4), after 
45 cycles of PCR at 95°C 15 s, 54°C 25 s, 72°C 20 s. 
in peritoneal mast cells, we developed a procedure to 
isolate RNA from a small number of mast cells. Mast 
cells were purified using a metrizamide gradient, plated 
in glass bottomed chambers and individual mast cells 
aspirated into a glass micropipette under Normarski op- 
tics. Mast cells were readily distinguished from other cell 
types by their characteristic morphology. After collect- 
ing about 500 cells, the pipette tip was immersed into the 
lysis buffer and was broken by sonication. Total RNA 
was isolated in the presence of lo-20 pug of E. coli trans- 
fer RNA as a carrier [25], and then treated with hepari- 
nase I. Fig. 2B shows that this method resulted in suc- 
cessful PCR amplification of several gene products from 
both rat and mouse peritoneal mast cells, including /3- 
actin and the high affinity IgE receptor (FcsRI), a pro- 
tein that is uniquely expressed in mast cells and basophils 
[26,30]. As Fig. 3 shows, we were also able to obtain 
Rab3 PCR products from a few peritoneal mast cells. As 
A. B. 
Rab3B: 
4. Discussion 
We have presented evidence showing that peritoneal 
mast cells express two isotypes of Rab3 proteins, Rab3B 
and Rab3D. These results strengthen the hypothesis that 
Rab3 proteins play a role in exocytosis in mast cells. We 
have previously shown that synthetic peptides corre- 
sponding to the Rab3A effector domain caused complete 
exocytotic degranulation in patch-clamped mast cells 
[l 11. However, since the putative effector domains for the 
different Rab3 isotypes are very similar we could not 
implicate a specific member of the Rab3 subfamily. We 
can now postulate that the Rab3 peptides are probably 
mimicking the action of Rab3B or Rab3D. It is not 
known which of the two isotypes regulates oxocytosis in 
mast cells; Rab3B and Rab3D have been shown to play 
a role in exocytosis in pituitary cells [9] and in adipocytes 
200 bp- 
LQIWDTAGQE 
Rab3D: 
GACCAGAATI-ITGATI-ATATGlTCAAACTGClTtT _GAT~GG&%ACAGCAGCGT~G~AAG 
ACCrCClTCCWITCCGCTATGC~GATGA~CCTTCACCCC~GCClTCGTGAGCAC&iTGG 
cC_A~GAClTCAA~~MGACAGT~AC~G~CATGA@4GAGGATCAAGffGCAGATtJ 
GGGACACAGCAGGACAA_GAA 
DQNFDYMFKLL~IGNSSVGKTSFLFRYADD~~PAFVSTVGIDFKVK’I’VYR@KR~K 
LQIWDTAGQE 
Fig. 3. PCR cloning and sequencing of Rab3 RNA transcripts in peritoneal mast cells. (A) PCR products obtained with specific primers for Rab3 
proteins. The cDNA isolated from about 500 rat peritoneal mast cells was subjected to 45 cycles of PCR at 94°C 15 s, 45°C 30 s, 72°C 20 s. The 
PCR products obtained with the Rab3 degenerate primers were subcloned into a pCRI1 vector. As shown, the subcloned PCR products migrated 
as a single band of 230 bp in a 3% agarose gel (where the additional bases correspond to the two pCRI1 segments between the mast cell inserts and 
the EcoRI sites in the cloning vector). (B) Nucleotide and predicted amino acid sequence of the Rab3 PCR products obtained from rat peritoneal 
mast cells were 100% identical to Rab 38 and Rab 3D. The areas where Rab 3B and Rab 3D are distinct from each other are underlined. Differences 
both at the nucleotide and predicted amino acid level are shown. 
174 
[8], respectively. Using specific antibodies, it has been 
shown that human platelets [31] and rat mast cells [32] 
express Rab3B but not Rab3A. Interestingly, it was 
shown that secretion of histamine was associated with 
the phosphorylation of Rab3B [32]. This raises the possi- 
bility that Rab3B may be the isotype that participates in 
exocytosis in mast cells. However, it is also possible that 
both proteins, Rab3B and Rab3D, participate in differ- 
ent branches of regulated exocytosis in the mast cell. 
Further experimentation is required to resolve this ques- 
tion. 
We found that the heparin contained in the mast cell 
secretory granules inhibits RT-PCR. This result may ex- 
plain why it has been so frustrating to study mast cells 
using molecular biological techniques. It is difficult to 
prepare acceptable yields of high quality RNA from 
mast cells using conventional RNA isolation techniques 
such as guanidinium isothiocyanate and centrifugation 
through cesium chloride [19,20]. The isolated RNA has 
been used for Northern blot analysis [33], in vitro trans- 
lation of proteins [20] and amplification of cDNA frag- 
ments using PCR [26]. However, in order to prepare 
acceptable quantities of good quality RNA a surpris- 
ingly large number of mast cells were needed in all these 
studies (more than 2 x IO7 cells or 20-50 rats per experi- 
ment!). It was therefore suggested that mast cells have a 
limited protein synthetic capacity and contain extremely 
low amounts of mRNA [19]. Because of these problems, 
almost all the molecular biology of mast cell gene prod- 
ucts has been performed using transformed (e.g. rat 
basophilic leukemia) and non-transformed (e.g. bone 
marrow derived mast cells) ‘mast cell like’ cell lines. 
However, these cells are only distant models for the 
highly differentiated mature peritoneal mast cells. We 
now have shown that the difficulties in using PCR in the 
peritoneal mast cells are created by heparin that copuri- 
fies with the RNA. Heparin has been shown to bind 
nonspecifically to oligonucleotides [27]. several oligonu- 
cleotide binding proteins (like RNA polymerase [34]), 
inhibit reverse transcription and PCR [29], and inhibit 
gene expression [35]. Analysis of RNA from tissues rich 
in proteoglycans uch as skeletal tissues has also been 
shown to be difficult since proteoglycans copurify with 
the RNA and decrease the sensivitity of Northern blots 
[36]. The methods described here should simplify studies 
of the function of gene products in native mast cells. 
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